Alnylam Pharmaceuticals, Inc.'s Net Worth
Alnylam Pharmaceuticals, Inc.'s net worth is estimated to be at least $9,148,512.68 as of 05/17/2024. CoreStreet's estimation of Alnylam Pharmaceuticals, Inc.'s net worth is based on their sale of stock and current holding of stock.
Alnylam Pharmaceuticals, Inc. is Major Shareholder at Regulus Therapeutics Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,000,000 units of RGLS stock on 02/23/2016. Their biggest sale was on 02/23/2016 when they sold 1,000,000 units of Regulus Therapeutics Inc stock for $7,180,000.00. They typically trade 7 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $9,148,512.68
Most recent insider trade:
- Feb. 23, 2016
Alnylam Pharmaceuticals, Inc.'s Insider Trading History
| Regulus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 23, 2016 | Major Shareholder | 1,000,000 | $7.18 | Sell | $7,180,000.00 |
Oct. 24, 2014 | Major Shareholder | 113,084 | $14.02 | Sell | $1,585,437.68 |
Oct. 10, 2014 | Major Shareholder | 2,000 | $6.41 | Sell | $12,820.00 |
Oct. 3, 2014 | Major Shareholder | 10,300 | $6.74 | Sell | $69,422.00 |
Sept. 26, 2014 | Major Shareholder | 2,500 | $7.04 | Sell | $17,600.00 |
Sept. 25, 2014 | Major Shareholder | 2,500 | $7.12 | Sell | $17,800.00 |
Sept. 24, 2014 | Major Shareholder | 3,750 | $7.19 | Sell | $26,962.50 |
Sept. 19, 2014 | Major Shareholder | 7,700 | $7.31 | Sell | $56,287.00 |
Sept. 12, 2014 | Major Shareholder | 8,900 | $7.85 | Sell | $69,865.00 |
Aug. 22, 2014 | Major Shareholder | 5,250 | $6.75 | Sell | $35,437.50 |
Aug. 21, 2014 | Major Shareholder | 2,500 | $6.89 | Sell | $17,225.00 |
Aug. 20, 2014 | Major Shareholder | 3,000 | $7.14 | Sell | $21,420.00 |
Aug. 15, 2014 | Major Shareholder | 1,450 | $6.98 | Sell | $10,121.00 |
Aug. 14, 2014 | Major Shareholder | 1,750 | $7.04 | Sell | $12,320.00 |
Aug. 13, 2014 | Major Shareholder | 2,250 | $7.02 | Sell | $15,795.00 |